Efficiency and relevance of post-exposure prophylaxis prescription by emergency physicians: a monocentric retrospective study
DOI:
https://doi.org/10.26738/poem.v1i1.12Abstract
Abstract
Background: Preventing infection with HIV remains a major public health challenge. Exposed persons are offered support and quick access to the post-exposure prophylaxis (PEP) by hospital emergency services. To investigate the accuracy of the prescription of emergency PEP for patients with sexual fluid exposure in a French emergency department (ED) by comparing data in medical files and actual prescriptions.
Methods: We retrospectively collected data for patients consulting for sexual exposure in a single Parisian ED from 2015 to 2016. For each patient, researchers independently checked whether the emergency physician prescribed PEP according to French guidelines. Our primary outcome was the appropriateness of the emergency PEP prescription after sexual fluid exposure. We calculated the Cohen weighted kappa coefficient with its 95% confidence interval (CI) for determining the agreement in indication for PEP.
Results: We included 346 patients in the analysis. Half of the patients were men who had sex with men (n=178). The most frequent sexual exposure was anal insertive or receptive (n=177; 51%). PEP was prescribed in 94% of cases (n=328). In 33 cases (10%) the indication for PEP was not clear, but PEP was prescribed in 17 cases (52%). The Kappa value for determining the indication for PEP was 0.55 (95% confidence interval 0.36-0.74), indicating poor agreement for prescription. The agreement was lowest for men who had sex with men: 0.29 (0.05-0.53).
Conclusion: Strategies are needed to improve the relevance of the prescription of PEP in French EDs to avoid the excess secondary effects and cost.
References
UNAIDS. The gap report. [Internet]. 2014 Jul (cited 2017 September 6). Available from: http://www.unaids.org/en/resources/documents/2014/20140716_UNAIDS_gap_report
Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, Ho DD. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med. 1996 Jan 1;183(1):215-25. doi: 10.1084/jem.183.1.215. PMID: 8551225; PMCID: PMC2192425.
Hsieh YH, Kelen GD, Laeyendecker O, Kraus CK, Quinn TC, Rothman RE. HIV Care Continuum for HIV-Infected Emergency Department Patients in an Inner-City Academic Emergency Department. Ann Emerg Med. 2015 Jul;66(1):69-78. doi: 10.1016/j.annemergmed.2015.01.001. Epub 2015 Feb 23. PMID: 25720801; PMCID: PMC4478148.
Chen GX, Jenkins EL. Potential work-related bloodborne pathogen exposures by industry and occupation in the United States part I: an emergency department-based surveillance study. Am J Ind Med. 2007 Mar;50(3):183-90. doi: 10.1002/ajim.20431. PMID: 17290363.
Groupe d’experts pour la prise en charge du VIH Sous la direction du Pr Philippe MORLAT, et sous l’égide du CNS et de l’ANRS. Prise en charge des accidents d’exposition sexuelle et au sang (AES) chez l’adulte et l’enfant [Internet]. 2017 Sep (cited 2021 March 1). Available from: https://cns.sante.fr/wp-content/uploads/2017/10/experts-vih_aes.pdf
Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, Gomaa A, Panlilio AL; US Public Health Service Working Group. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol. 2013 Sep;34(9):875-92. doi: 10.1086/672271. Erratum in: Infect Control Hosp Epidemiol. 2013 Nov;34(11):1238. Dosage error in article text. PMID: 23917901.
Cresswell F, Waters L, Briggs E, Fox J, Harbottle J, Hawkins D, Murchie M, Radcliffe K, Rafferty P, Rodger A, Fisher M. UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015. Int J STD AIDS. 2016 Aug;27(9):713-38. doi: 10.1177/0956462416641813. Epub 2016 Apr 19. PMID: 27095790.
Antinori A, Di Biagio A, Marcotullio S, Andreoni M, Chirianni A, d'Arminio Monforte A, Galli M, Mazzotta F, Mussini C, Puoti M, Lazzarin A; Italian HIV Guidelines Working Group. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016. New Microbiol. 2017 Apr;40(2):86-98. PMID: 28513816.
Cazein F, Le Strat Y, Sarr A, Ramus C, Bouche N, Pillonel J, et al. Dépistage de l'infection par le VIH en France, 2003-2015. Bull Epidémiol Hebd. 2016;(41-42):745-8. [Internet] Available from: http://invs.santepubliquefrance.fr/beh/2016/41-42/2016_41-42_2.htm
Pavel S, Burty C, Alcaraz I, de la Tribonnière X, Baclet V, Ajana F, Mouton Y, Rabaud C, Yazdanpanah Y. Severe liver toxicity in postexposure prophylaxis for HIV infection with a zidovudine, lamivudine and fosamprenavir/ritonavir regimen. AIDS. 2007 Jan 11;21(2):268-9. doi: 10.1097/QAD.0b013e328011aa35. PMID: 17197833.
Dellamonica P, Katlama C, Lévy-Bachelot L, Daures J-P, Finkielsztejn L. Abacavir (Ziagen(®)) use between 2003 and 2008 in France according to the electronic medical record NADIS(®). Med Mal Infect. 2013 Dec;43(11-12):467-74. https://doi.org/10.1016/j.medmal.2013.09.012
Kelen GD, Hsieh YH, Rothman RE, Patel EU, Laeyendecker OB, Marzinke MA, Clarke W, Parsons T, Manucci JL, Quinn TC. Improvements in the continuum of HIV care in an inner-city emergency department. AIDS. 2016 Jan 2;30(1):113-20. doi: 10.1097/QAD.0000000000000896. PMID: 26731757; PMCID: PMC4704105.
Stanley K, Lora M, Merjavy S, Chang J, Arora S, Menchine M, Jacobson KR. HIV Prevention and Treatment: The Evolving Role of the Emergency Department. Ann Emerg Med. 2017 Oct;70(4):562-572.e3. doi: 10.1016/j.annemergmed.2017.01.018. Epub 2017 Mar 25. PMID: 28347557.
Institut National de la Veille Sanitaire (INVS). Incidence de l'infection par le VIH (2013) [Internet] Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/infections-sexuellement-transmissibles/vih-sida/donnees/#tabs
Ministère de la santé. Prise en charge des situations d’exposition au risque viral [Internet]. 2016 (cited 2017 November 1). Available from: http://www.sante.gouv.fr/IMG/pdf/18_Prise_en_charge_des_situations_d_exposition_au_risque_viral.pdf
Hivinfo. Non-occupational Post-Exposure prophylaxis (nPEP) 2021. [Internet] Available from: https://hivinfo.nih.gov/understanding-hiv/fact-sheets/post-exposure-prophylaxis-pep
Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics. 1977 Jun;33(2):363-74. PMID: 884196.
Von Elm E, Altman DG, Egger M, Pocock S, Gøtzsche P, Jan P. Vandenbroucke J. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Ann Intern Med. 2007 Oct 16;147(8):573-577.
https://doi.org/10.7326/0003-4819-147-8-200710160-00010
O'Donnell S, Bhate TD, Grafstein E, Lau W, Stenstrom R, Scheuermeyer FX. Missed Opportunities for HIV Prophylaxis Among Emergency Department Patients With Occupational and Nonoccupational Body Fluid Exposures. Ann Emerg Med. 2016 Sep;68(3):315-323.e1. doi: 10.1016/j.annemergmed.2016.03.027. Epub 2016 Apr 22. PMID: 27112264.
Merchant RC, Becker BM, Mayer KH, Fuerch J, Schreck B. Emergency department blood or body fluid exposure evaluations and HIV postexposure prophylaxis usage. Acad Emerg Med. 2003 Dec;10(12):1345-53. doi: 10.1111/j.1553-2712.2003.tb00009.x. PMID: 14644787.
McCausland JB, Linden JA, Degutis LC, Ramanujam P, Sullivan LM, D'onofrio G. Nonoccupational postexposure HIV prevention: emergency physicians' current practices, attitudes, and beliefs. Ann Emerg Med. 2003 Nov;42(5):651-6. doi: 10.1016/S019606440300338X. PMID: 14581917.
Clinician Consultation Center. PEP Guidelines. [Internet] 2016 Apr (Cited 2017 September 6). Available from: https://nccc.ucsf.edu/clinical-resources/pep-resources/pep-guidelines/
Riou, B. 2017 : l’an 1 du diplôme d’études spécialisées de médecine d’urgence. Ann. Fr. Med. Urgence. 2017;(7):1–4. doi: https://doi.org/10.1007/s13341-017-0710-z
Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Préau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Doré V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF; ANRS IPERGAY Study Group. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1. PMID: 26624850.
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30;363(27):2587-99. doi: 10.1056/NEJMoa1011205. Epub 2010 Nov 23. PMID: 21091279; PMCID: PMC3079639.
McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, Sullivan AK, Clarke A, Reeves I, Schembri G, Mackie N, Bowman C, Lacey CJ, Apea V, Brady M, Fox J, Taylor S, Antonucci S, Khoo SH, Rooney J, Nardone A, Fisher M, McOwan A, Phillips AN, Johnson AM, Gazzard B, Gill ON. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016 Jan 2;387(10013):53-60. doi: 10.1016/S0140-6736(15)00056-2. Epub 2015 Sep 9. PMID: 26364263; PMCID: PMC4700047.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Xavier Eyer, Youri Yordanoff, Dominique Pateron, Patrick Plaisance, Anthony Chauvin
This work is licensed under a Creative Commons Attribution 4.0 International License.
